IVF programs do no result in successful outcome pregnancy most commonly due to these reasons:
Embryo transfer cancellations can also happen if the patient develops complications such as ovarian hyperstimulation syndrome (OHSS).
With the development of the SEGOVA program, a new option is offered for women with a history of failed IVF cycles.
SEGOVA ovarian rejuvenation is a program designed to help boost the ovaries to restore proper folliculogenesis and contribute with the sources of signaling molecules in the ovaries to achieve an adequate environment for oocyte development.
SEGOVA is a group of methods based on biological therapy using autologous, natural, safe sources that can help retrieve the impaired ovarian function and balance hormone production in hormone-secreting cells. It provides benefit by restoring the endocrine homeostasis and boosting the local ovarian environment to help obtain good quality oocytes and successful reproductive outcomes.
Professor Aleksandar Ljubić (pictured), MD PhD is the President of Forever Young Holding – international biotech holding dedicated to use and development of cutting edge biotechnology products and services with the aim to increase overall health, human longevity and quality of life.
He is a pioneer in invasive ultrasound-guided fetal procedures, direct maturation of fetal lungs, inventor of method of prenatal hearing screening (PHS) (Sovilj-Ljubic), non-surgical fibroids treatment, and advanced NOTES laparoscopic procedures.
His main research areas are biotechnology in reproductive and perinatal medicine, assisted reproduction and minimally invasive reproductive surgery.
We’d love to hear from you!
Our doctors are available for a free no obligation consultation every day.
Email Us
Quick Links